“We need to make it easier for project managers” in clinical research.
“The clinical trial industry passed the COVID-19 test by working together with purpose, dedication, and talent. I believe our best days are ahead of us and I look forward to being part of it…”
The current site selection model is flawed: a site’s true potential is stifled when the wrong trials come their way. With a huge portion of trials going to large academic research centers, the remaining majority of sites with experienced, motivated teams feel obligated to accept nearly every opportunity they receive – even the ones that aren’t a match for their team and patients.
“Bring together the study team… and make it a true cross-functional exercise.” Read on for more tips for creating a robust clinical trial risk management program.
What does the future look like for getting more would-be trial participants past the “interested” phase and into the “volunteer” phase?